Related Experiment Video
Updated: Aug 11, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
Vesna Sossi1, Raúl de la Fuente-Fernández, Michael Schulzer
1University of British Columbia, Vancouver, Canada. vesna@physics.ubc.ca
Brain : a Journal of Neurology
|February 16, 2006
Summary
Younger Parkinson's patients show greater dopamine turnover alterations, contributing to motor complications. This suggests pre-synaptic changes are key to age-related differences in treatment side effects.
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Parkinson's disease (PD) motor complications are linked to pre-synaptic dopamine alterations.
- Younger age of onset in PD correlates with increased motor complications.
Purpose of the Study:
- To investigate the age-dependent changes in dopamine (DA) turnover in Parkinson's disease.
- To explore if altered DA turnover contributes to age-related motor complications.
Main Methods:
- Utilized positron emission tomography (PET) with 18F-fluorodopa (FD) scans.
- Measured dopamine turnover (effective DA distribution volume - EDV) and synthesis/storage (Ki) in 27 PD patients (38-79 years).
Main Results:
- Found a significant negative correlation between age and decreased EDV and Ki in the putamen.
- Observed a greater relative increase in DA turnover versus decrease in synthesis/storage in younger patients.
Conclusions:
- Younger-onset PD patients exhibit more significant alterations in DA turnover.
- This imbalance in dopamine synthesis, storage, and release likely contributes to motor fluctuations and complications in younger patients.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...